在2021-2022年期间通过墨西哥过境的移民中检查COVID-19疫苗接种范围和可接受性:来自庇护所调查和采访的见解
René Leyva-Flores1, Belkis Aracena-Genao2, Christine Allen3
1Center for Research in Health Systems (CISS), National Institute of Public Health (INSP), Cuernavaca, Morelos, Mexico.
PloS one
|July 11, 2025
概括
墨西哥的许多移民在抵达之前已经接种了疫苗,但不一致的身份证和年龄限制阻碍了进一步的COVID-19疫苗覆盖. 解决错误信息是改善这一弱势群体获取信息的关键.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 移民研究 移民研究
背景情况:
- 墨西哥在为各种移民群体 (包括非法移民,寻求庇护者和难民) 实现COVID-19疫苗接种方面遇到了挑战.
- 之前的研究发现了影响移民接种疫苗的优先级政策,识别需求和社会人口因素,但这些在墨西哥背景下未得到充分探索.
研究的目的:
- 分析通过墨西哥过境的移民中与COVID-19疫苗覆盖率相关的因素.
- 识别移民人口对COVID-19疫苗接种的障碍和态度.
主要方法:
- 从2021年11月到2022年5月,在六个避难所对2,355名移民进行了一项调查,评估了疫苗接种史,接受度以及社会人口统计学,移民和健康特征.
- 与移民和关键信息人进行的半结构面试探讨了接入障碍和接种疫苗的态度.
主要成果:
- 61.1%的受访移民至少接种了一剂COVID-19疫苗,其中67.6%在进入墨西哥之前接种了疫苗.
- 接种疫苗与高等教育水平,先前居住的国家,先前的COVID-19感染和先前的COVID-19测试有关.
- 在未接种疫苗的人群中,81.4%的人愿意接种疫苗,理由是保护和旅行要求;7.2%的人对错误信息表示担忧.
结论:
- 虽然抵达前接种疫苗是常见的,但墨西哥境内不一致的识别要求和年龄限制限制限制了整体疫苗覆盖率.
- 解决错误信息问题,并使当地疫苗接种实践与国家政策保持一致,对于提高移民接种疫苗的机会至关重要.
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Migration
8.1K
Migration is long-range, seasonal movement from one region or habitat to another. This common strategy, carried out by many different organisms around the world, is an adaptive response that typically corresponds to changes in an organism’s environment, like resource availability or climate. Migrations can involve huge groups of thousands of animals as well as single individuals traveling alone and can range from thousands of kilometers to just a few hundred meters.
8.1K
Prevalence and Incidence
825
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
825
Transmission-based Precautions I: Contact, Enteric, and Droplets
4.1K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.1K
Sexually Transmitted Infections
416
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
416
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517


